150 related articles for article (PubMed ID: 3549761)
1. Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids.
Cohen JC; Hickman R
J Clin Endocrinol Metab; 1987 May; 64(5):960-3. PubMed ID: 3549761
[TBL] [Abstract][Full Text] [Related]
2. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents.
Pärssinen M; Kujala U; Vartiainen E; Sarna S; Seppälä T
Int J Sports Med; 2000 Apr; 21(3):225-7. PubMed ID: 10834358
[TBL] [Abstract][Full Text] [Related]
3. Glucose tolerance and insulin response to glucose load in body builders.
Szczypaczewska M; Nazar K; Kaciuba-Uscilko H
Int J Sports Med; 1989 Feb; 10(1):34-7. PubMed ID: 2649445
[TBL] [Abstract][Full Text] [Related]
4. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
Curry LA; Wagman DF
Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and insulin resistance in childhood obesity.
Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
[TBL] [Abstract][Full Text] [Related]
6. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
7. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
8. Glucose tolerance and lipid-lipoprotein levels in middle-aged powerlifters.
Hurley BF; Hagberg JM; Seals DR; Ehsani AA; Goldberg AP; Holloszy JO
Clin Physiol; 1987 Feb; 7(1):11-9. PubMed ID: 3545652
[TBL] [Abstract][Full Text] [Related]
9. Urine sodium excretion in response to an oral glucose tolerance test in obese and nonobese adolescents.
Finta KM; Rocchini AP; Moorehead C; Key J; Katch V
Pediatrics; 1992 Sep; 90(3):442-6. PubMed ID: 1518704
[TBL] [Abstract][Full Text] [Related]
10. Obese children with low birth weight demonstrate impaired beta-cell function during oral glucose tolerance test.
Brufani C; Grossi A; Fintini D; Tozzi A; Nocerino V; Patera PI; Ubertini G; Porzio O; Barbetti F; Cappa M
J Clin Endocrinol Metab; 2009 Nov; 94(11):4448-52. PubMed ID: 19820011
[TBL] [Abstract][Full Text] [Related]
11. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
[TBL] [Abstract][Full Text] [Related]
12. Ingestion of androgenic-anabolic steroids induces mild thyroidal impairment in male body builders.
Deyssig R; Weissel M
J Clin Endocrinol Metab; 1993 Apr; 76(4):1069-71. PubMed ID: 8473383
[TBL] [Abstract][Full Text] [Related]
13. Androgenic anabolic steroids also impair right ventricular function.
Kasikcioglu E; Oflaz H; Umman B; Bugra Z
Int J Cardiol; 2009 May; 134(1):123-5. PubMed ID: 18272244
[TBL] [Abstract][Full Text] [Related]
14. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
Sabuncu T; Ucar E; Birden F; Yasar O
Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
[TBL] [Abstract][Full Text] [Related]
15. Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.
Beer NA; Jakubowicz DJ; Beer RM; Arocha IR; Nestler JE
J Clin Endocrinol Metab; 1993 Jan; 76(1):178-83. PubMed ID: 8421087
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis?
Pertusi R; Dickerman RD; McConathy WJ
J Am Osteopath Assoc; 2001 Jul; 101(7):391-4. PubMed ID: 11476029
[TBL] [Abstract][Full Text] [Related]
17. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2010 Jul; 95(7):3309-17. PubMed ID: 20410219
[TBL] [Abstract][Full Text] [Related]
18. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
[TBL] [Abstract][Full Text] [Related]
19. Body image, disordered eating, and anabolic steroids in male bodybuilders: current versus former users.
Goldfield GS; Woodside DB
Phys Sportsmed; 2009 Apr; 37(1):111-4. PubMed ID: 20048495
[TBL] [Abstract][Full Text] [Related]
20. Increased insulin resistance in obese, glucose-intolerant Southwestern American Indians: evidence for a defect not explained by obesity.
Nagulesparan M; Savage PJ; Mott DM; Johnson GC; Unger RH; Bennett PH
J Clin Endocrinol Metab; 1980 Oct; 51(4):739-43. PubMed ID: 6106647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
